THEMIS MEDICARE
Back to Income Statement
|
THEMIS MEDICARE Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1.14 Cr | ₹30 Cr | ₹44 Cr | ₹57 Cr | ₹73 Cr |
What is the latest Consolidated Net Profit of THEMIS MEDICARE ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹1.14 Cr |
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹73 Cr |
How is Consolidated Net Profit of THEMIS MEDICARE Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1.14 Cr | -96.17 | |
| Mar2025 | ₹30 Cr | -31.46 | |
| Mar2024 | ₹44 Cr | -23.51 | |
| Mar2023 | ₹57 Cr | -21.93 | |
| Mar2022 | ₹73 Cr | - | |
Compare Consolidated Net Profit of peers of THEMIS MEDICARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THEMIS MEDICARE | ₹1,050.9 Cr | -2.6% | -7.8% | -17.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
THEMIS MEDICARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THEMIS MEDICARE | -2.6% |
-7.8% |
-17.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses